Skip to main content
. 2016 Dec 19;27(9):2610–2626. doi: 10.1177/0962280216683570

Table 1.

Treatment effect estimates for fat free mass (kg) at 7 years corrected age from the Docosahexaenoic Acid for the Improvement of Neurodevelopmental Outcome in Preterm Infants trial.

Method of analysis Mean difference Standard error 95% confidence interval
Unadjusted CCA −0.007 0.259 −0.514, 0.500
CCA 0.048 0.238 −0.420, 0.515
MI overall m = 50 −0.104 0.233 −0.562, 0.353
MI by group m = 50 −0.118 0.227 −0.563, 0.327
Linear mixed model −0.097 0.231 −0.551, 0.356
HHS Vulnerability Disclosure